F Prime, Inc.

ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.

RiskLens, Inc. provides cyber risk management software. It offers Cyber Risk Maturity, an applied maturity model that measures an organization’s ability to manage risk over time and its compliance against NIST CSF; Cyber Risk Triage, a rapid risk assessment tool that helps determine, which new cyber risk scenarios deserve a full risk analysis; Cyber Risk Third-Party, a risk assessment solution for organizations to assess the risk management practices of third parties, such as vendors, partners, cyber insurance buyers, or acquisition targets; Cyber Risk Quantification, a decision-support application that quantifies an organization's financial risk exposure to cyber security events; and standard value at risk model for cyber security and operational risk. The company also provides a suite of SaaS applications that enables chief information risk officers and chief information security officers to quantify and manage cyber risk from the business perspective; and empowers enterprises and government organizations to manage cyber risk. In addition, it offers professional services; factor analysis of information training and certification; and application training services. The company serves financial services, government, healthcare, education, and technology markets. RiskLens, Inc. was formerly known as CXOWare, Inc. The company was incorporated in 2011 and is based in Spokane, Washington.

Hile is an animal vaccine manufacturer Company.

Latchel provides an operations platform intended to track maintenance and vendor selection. The company's platform provides maintenance tracking and vendor selection services by property management companies to track maintenance requests, increase net margins, and increase renter satisfaction via mobile application, enabling users to connect automatically with the tenants. Latchel was founded on 2016 and is based in Seattle, Washington.

Apellis Pharmaceuticals, Inc. is an early stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (COPD). Apellis emerged from a successful transaction between Potentia Pharmaceuticals, Inc. and Alcon Research, Ltd in October 2009 in which Alcon licensed the ocular applications of Potentia’s family of complement inhibitors. Apellis holds the worldwide exclusive rights to the extra-ocular uses of these compounds. In May 2010, with start-up capital raised from private investors, Apellis commenced full-scale operations.

Simon Data is the enterprise Customer Data Platform (CDP) that empowers brands to deliver data-driven, personalized customer experiences anywhere.The platform leverages enterprise-scale big data and machine learning to power customer communications in any channel. Simon’s unique approach allows brands to develop and deliver incredible personalization capabilities without needing to build and maintain massive bespoke data infrastructure. At Simon, our goal is to improve and optimize customer experiences by making the entire process, experimentation through analysis, a data-driven one.

Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

MoEngage, Inc. provides a user analytics and engagement platform to improve customer retention and lifetime values. Its platform enables user intelligence, push notification, in-app messaging, and smart triggering aspects. The company serves e-commerce, telecom, travel and hospitality, and banking and finance industries. MoEngage, Inc. has a strategic partnership with Vidora, Inc. The company was founded in 2014 and is based in San Francisco, California. It has additional offices in Bengaluru, India; Singapore; London, United Kingdom; Jakarta, Indonesia; Bangkok, Thailand; H? Chí Minh, Vietnam; and Berlin, Germany.

Innovusion is a leading developer of image grade LiDAR sensor systems for the level 4 and 5 of the autonomous vehicle and ADAS markets. Their unique combination of range, resolution, hardware accelerated sensor fusion, compact size, ease of integration and cost effectiveness makes our products the ideal choice for the most demanding applications. We are venture-backed and headquartered in the heart of Silicon Valley.

91streets Media Technologies Private Limited develops an application to order medicines and diagnostic tests. The company was incorporated in 2014 and is based in Mumbai, India.

Vendr buys and renews software for companies. Vendr is the way that scaling companies buy software. Vendr helps companies save a significant amount of time, and a material amount of money, every time they buy and renew SaaS. Vendr is trusted by the world's fastest-growing b2b and b2c companies.

Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody. Adagene was founded in 2011 and is based in Suzhou, China.

Zenflow, Inc. develops and markets a spring device that provides relief for permanent BPH symptoms in men. The company provides solutions for urinary obstruction without destroying tissues. It offers its products for patients and urologists. The company was formerly known as Torix Medical, Inc. The company was founded in 2014 and is based in San Francisco, California.

Proximie is a secure software solution which expands virtual surgical collaboration enabling surgeons to share expertise using augmented reality tools before, during and after surgery. Bringing together experts remotely, it pushes the boundaries of time and distance for real and impactful scaling of surgical knowledge.

Expressable is an online speech therapy practice for everyone with a communication disorder. It has pioneered a parent-focused care model that uses technology and education to integrate speech therapy techniques into children's daily lives, improving outcomes and experiences. The company was founded in 2019 and is headquartered in Austin, Texas.

CareStack is a single all-in-one platform on the cloud that combines dental practice management, patient engagement, practice marketing, and data analytics. CareStack is currently used by large and growing practices as an all-in-one solution to increase productivity, minimize costs, and improve patient dental care. CareStack's mission is to help dentists to have a better practice and a better life. Through their technology-led offerings, CareStack will elevate dental offices to a higher degree of financial success.

Renshu Medical is an otolaryngology specialist chain covering areas such as suppurative otitis media, allergic rhinitis, chronic sinusitis and thyroid cancer. It provides users with Danish ear hearing detection, nasal endoscopy video examination and nasopharyngoscopy, specialists test report interpretation and other services; and can use WeChat appointment appointment time, appointment hospital experts.

ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization.

Ivenix is a medical technology company that develops a next-generation infusion management system. It is a venture-backed medical device company with a vision to transform infusion delivery in every care setting, globally. The company is focused on bringing its first product to market, a new and innovative infusion management system for hospitals. The system combines integrated state-of-the-art information technology and simplicity with an adaptive fluid delivery platform that continuously measures flow. The company was founded in 2007 and is headquartered in Amesbury, Massachusetts.

Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Sanofi-Topaz (formerly Topaz Pharmaceuticals) develops and manufactures pharmaceutical products for children’s health issues. It provides various drugs for the treatment of head lice, acne, and infections, as well as vaccines against childhood diseases. Sanofi-Topaz was founded in 2005 and is headquartered in Horsham, Pennsylvania.

Fluidnet was founded in 2002 by a group of medical device professionals who collectively have over 100+ years of industry experience and product innovations. Based on the seacoast of scenic New Hampshire, Fluidnet is just north of Boston, providing access to a rich medical device community and first-rate research and development skills and facilities.

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Xilio Therapeutics is a biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. The company’s tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects. The broad applicability of these therapies across cancer types means that all patients could benefit from these potentially curative medicines. These tumor-selective therapies are designed to overcome the significant toxicities associated with validated IO therapies, such as IL-2 and aCTLA4, which have historically limited the number of patients that can be treated and prevented patients from completing full courses of treatment Xilio Therapeutics proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. The company applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. Xilio Therapeutics was founded in 2016 and is headquartered in Waltham, Massachusetts, United States.

BenchSci's vision is to bring medicine to patients 50% faster by 2025. The company empowers scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science at 15 top 20 pharmaceutical companies and over 4,300 leading research centers worldwide. BenchSci is a CIX Top 10 Growth company, certified Great Place to Work®, and top-ranked company on Glassdoor.

ReadMe.io Co. provides documentation services. It allows users to set up a developer hub; and offers custom JavaScript, custom HTML, user management, two-factor authentication, documentation migration, custom feature development, consultation, and custom themes and layout solutions. The company provides document collaboration, API, markdown-based drag-and-drop document editing, and document versioning solutions, as well as application keys. The company was founded in 2014 and is based in San Francisco, California.

AvantStay is a technology-first hospitality brand for group travel. It delivers affordable, world-class, authentic, tech-enabled short-term rental (STR) group experiences targeted at the millennial generation. AvantStay was founded in 2017 and is headquartered in Los Angeles, California.

Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.

Codeship's continuous integration platform operates B2D portal that delivers hosted continuous integration and deployment for web applications. It shortens the development cycles thus reducing the risk of bugs and increasing innovation. It helps software companies to develop a better product faster by taking care of the testing and release process. Codeship automates software deployment and all the necessary tasks involved with it.

Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system to defeat cancer. It offers XTX201, a solution that induces immune activity in tumors and demonstrates improved antitumor activity. The company’s tumor-selective immunotherapies are based on its technology, which maximizes the potency of immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects. Xilio Therapeutics, Inc. was formerly known as Akrevia Therapeutics, Inc. and changed its name to Xilio Therapeutics, Inc. in March 2020. The company was incorporated in 2015 and is based in Waltham, Massachusetts.

ownCloud is the company behind the ownCloud project – the most downloaded open source project for data and file sync, share and view. ownCloud enables businesses to host their own, on premises or remote, cloud storage while maintaining regulatory and compliance needs. Located in Boston, Massachusetts with an international office in Germany we offer your cloud with your data – your way!

Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.

Proximie is a secure software solution which expands virtual surgical collaboration enabling surgeons to share expertise using augmented reality tools before, during and after surgery. Bringing together experts remotely, it pushes the boundaries of time and distance for real and impactful scaling of surgical knowledge.

TradeBlock offers financial institutions with a range of execution and analysis tools for digital currency markets. The company acts as a global source of data which shares analyses on market data relating to cryptocurrencies, trading, regulations, mining, protocol updates, block chain analysis, and economic developments. TradeBlock was founded in 2013 and is based in New York, United States.

Snapsheet is a pioneer in virtual appraisals and a leader in cloud-native claims management software, enabling the most innovative claims organizations to deliver the best experiences for customers. With a focus on engagement, digitization, and intelligent automation, Snapsheet provides unmatched technology and processes that improve customer experience, drive greater organizational agility, and deliver transformational benefits through its Snapsheet Cloud software suite. Snapsheet leads the industry in claims innovation including the deployment of the fastest digital auto insurance claims process in the United States. As a trusted innovation partner, Snapsheet works with more than 100 clients, including many of the largest insurance carriers, third-party administrators, and insurtech and sharing economy disruptors.

SonderMind Inc. provides mental health services through a digital network of therapists and care providers. Its solution connects consumers with a therapist for video telehealth or in-person sessions. Its service areas include ADHD, addiction, anorexia, anxiety, binge eating, bipolar disorder, bulimia, depression, eating disorders, grief and loss, LGBTQ, obsessive compulsive disorder (OCD), PTSD, postpartum, and schizophrenia. The company was founded in 2017 and is based in Denver, Colorado.

Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.

Biopalette is a operator of a platform intended to offer gene-editing techniques. Bio Palette plans to develop our business in three fields, classified based on the type of cells targeted for genome editing.

Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

Hone Group Inc. develops and operates a platform for live online leadership and management training. It offers a development platform that enables companies to develop their people. The company also provides manager, diversity and inclusion, communication, conflict management, team building, and people skills training services. In addition, its platform finds, books, manages, and measures live online training programs; and provides customized support services for organization and individuals. Hone Group Inc. was incorporated in 2017 and is based in San Francisco, California.

Real Estate Equity Exchange, Inc., doing business as Unison Home Ownership Investors, makes long-term investments in individual residential properties through Unison HomeBuyer and Unison HomeOwner programs. It offers Unison HomeBuyer, which provides consumers half of the down payment funds needed to purchase a home; and Unison HomeOwner, which allows current homeowners to tap into their home equity without interest or monthly payments. The company was founded in 2004 and is based in San Francisco, California.

Valor Performance is digital learning platform focused on igniting and sustaining peak performance for managers and executives. Valor closes the professional training gap through a dynamic digital platform, progress metrics, and personalized programs for all Valor recipients – giving them a premium experience while fostering a performance mindset. Founded in 2017, Valor Performance is headquartered in Boston, Massachusetts.

Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Vestwell is a digital platform that makes it easier to offer and administer 401(k) plans. Vestwell removes traditional friction points through seamless plan design, automated onboarding, streamlined administration, and flexible investment strategies, all at competitive pricing. By acting as a single point of contact, Vestwell has modernized the retirement offering while keeping the plan sponsor's and plan participant's best interests in mind. The company was founded in 2016 and based in New York, New York.

Cytek Biosciences provides solutions that enable scientists to rapidly, efficiently obtain deep biological insights through high quality, high parametric datasets. Cytek manufactures and supplies flow cytometry products and services. Cytek’s compact, affordable instruments, and wide-ranging support offerings are used by researchers and clinicians all over the world. Cytek is focused on accelerating the adoption of flow cytometry to fuel scientific discovery. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before.

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.

Quicko Technosoft Labs Private Limited (also known as Whatfix) is a digital adoption platform that helps enterprises and businesses simplify their training and support efforts with easily accessible contextual information. Its platform is built with real-time interactive guidance technology at its core which helps users achieve optimal performance by providing just-in-time guidance that enables them to perform tasks quickly and efficiently.

Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.

Doceree Inc operates a programmatic physician engagement and advertising platform that helps publishers and advertisers purchase advertising space and target audiences. It provides access to physician-only platforms. The company serves media agencies, pharmaceutical brands, medical devices, consumer healthcare brands, and hospitals. The company was founded in 2019 and is based in Parsippany, New Jersey with an additional office in New Delhi, India.

Papaya is a developer of an online mobile bill payment application designed to simplify the financial transactions. The company's bill payment application offers multiple payment methods including debit and credit cards or directly from bank accounts, where personal information and payment data are encrypted and processed via HIPAA and PCI compliant methods, enabling users to pay bills faster and in a secure hassle-free method.

Vicept (Vicept Therapeutics, Inc.), based in Malvern, Pennsylvania, is a privately held specialty biopharmaceutical company founded in August, 2009 with a mission to develop the first effective topically applied-therapy directed toward the erythema (skin redness) of rosacea and other dermatologic disorders characterized by redness and or 'flushing' of the skin.

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.

K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.

Operator of an open marketplace enterprise platform intended to equip and enable payers to achieve accurate payments in the healthcare field. The company's platform offers a reference source repository, curated content, and payment accuracy technology, enabling users to reduce costs across the total cost for payment accuracy, find it easier to keep up with changes and innovate new concepts.

Embark Veterinary, Inc. was incorporated in 2015 and is based in Ithaca, New York.

Innovusion is a leading developer of image grade LiDAR sensor systems for the level 4 and 5 of the autonomous vehicle and ADAS markets. Their unique combination of range, resolution, hardware accelerated sensor fusion, compact size, ease of integration and cost effectiveness makes our products the ideal choice for the most demanding applications. We are venture-backed and headquartered in the heart of Silicon Valley.

At WelbeHealth, we envision a world in which every human being is able to participate fully in life through their final days. We serve frail seniors through a model of comprehensive medical and social care called PACE (Program of All-Inclusive Care for the Elderly), helping our participants live better, longer, and more independently. Founded by a seasoned group of physician entrepreneurs, our leadership team hails from leading payer and provider organizations such as GoHealth Urgent Care, BAYADA Home Health, AirStrip Technologies, Evolent Health, and On Lok. With funding from leading venture capital firms, we're looking for team members who are inspired to help us deliver on our mission of unlocking the full potential of the most vulnerable seniors in our communities. Our colleagues are energized by working in diverse groups toward our shared purpose, are eager to drive groundbreaking innovations, and have the courage to care for our participants with empathy and love.

Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The Company’s energetic team of world-renown biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.

Iora Health, Inc. operates a healthcare system that provides primary care services in the United States. It operates primary care practice for college employees and their adult dependents. The company also provides educational offerings, including group visits to help patients stay on track with their health. Iora Health, Inc. was founded in 2010 and is based in Boston, Massachusetts.

SKUteam founded in 2020: a transformational year for global businesses amidst a global pandemic, by a group of early former Flexport executives. Our vision is to democratize the production process in global manufacturing, starting with the apparel and home furnishing industries. SKUteam acts as your localised inspection agency, overseeing sample development and approvals, raw material inspections, in-line/top sample inspections and a final AQL inspection prior to ship out. SKUteam's unique platform will deliver an unprecedented level of visibility to take the guesswork out of the ever changing production process, ensuring brands can go to market fast, with confidence and the highest quality products.

Modis Therapeutics, Inc. develops disease modifying therapies for rare genetic diseases. The company designs and develops a therapy MT1621, which restores mitochondrial DNA replication fidelity. The company was incorporated in 2016 and is based in Oakland, California. As of September 6, 2019, Modis Therapeutics, Inc. operates as a subsidiary of Zogenix, Inc..

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's ground-breaking AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.

Accuri Cytometers was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument. As a result, the company is looking to develop affordable and robust cytometers.

Papaya is a developer of an online mobile bill payment application designed to simplify the financial transactions. The company's bill payment application offers multiple payment methods including debit and credit cards or directly from bank accounts, where personal information and payment data are encrypted and processed via HIPAA and PCI compliant methods, enabling users to pay bills faster and in a secure hassle-free method.

b-ONE Ortho Corp. develops orthopedic healthcare solutions. The company’s product includes B-One total hip system which features coating technology and instrumentation. The system includes the Juveno bone-conserving femoral prosthesis and the B-One primary acetabular systems. b-ONE Ortho Corp. was founded in 2015 and is based in Cedar Knolls, New Jersey. The company has additional offices in Shanghai and Suzhou, China.

Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

AmplifyMD is a telemedicine platform connecting over 3,300 medical institutions with a lack of specialty access, often in rural or small regions to a network of leading specialists.AmplifyMD provides both the clinical team as well as the software to streamline and automate virtual care delivery and billing workflows and integrates seamlessly with hospitals' existing EHRs.

Firefly Health provides primary health care services that redefines high quality patient care. The company uses sophisticated technology with a thoughtful care team experience for continuous, intelligent care that changes behavior and drives value by providing virtual-first primary care approach, live video appointments with primary care physician and team for convenience without any membership fees, allowing people to make smart choices about their health, while enabling clinicians to provide unparalleled, consistent, and proactive care.

Developer of intelligent medical devices designed for treatment of Parkinson and motor dysfunction. With research and development of intelligent monitoring and assistant devices, the company develops systematic systematic solutions to functional disorders for patients with Parkinson and motor dysfunction, enabling patients to monitor their physical activities and facilitate their movements.

Biopalette is a operator of a platform intended to offer gene-editing techniques. Bio Palette plans to develop our business in three fields, classified based on the type of cells targeted for genome editing.

TraceLink is the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte’s Technology Fast 500 (ranked number 293 in 2015), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. TraceLink is funded by FirstMark Capital, Volition Capital and F-Prime Capital.

Peptone Ltd develops and provides artificial intelligence (AI) solutions for addressing protein developability problems in biotechnology, biopharmaceutical, and life sciences industries. The company offers antibody designing and optimization, protein database, automated thermos-stability engineering, and hybrid AI deployment solutions. Additionally, it provides CassandraAI, a silico protein engineering platform. Peptone Ltd was founded in 2016 and is headquartered in London, United Kingdom.

As of March 9, 2020, Menlo Therapeutics Inc. was acquired by Foamix Pharmaceuticals Ltd., in a reverse merger transaction. Menlo Therapeutics Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the United States. The company has completed Phase II clinical trials in pruritus associated with prurigo nodularis; psoriasis; chronic pruritus; atopic dermatitis; and refractory chronic cough. The company was formerly known as Tigercat Pharma, Inc. and changed its name to Menlo Therapeutics Inc. in May 2016. Menlo Therapeutics Inc. was founded in 2011 and is headquartered in Redwood City, California.

Verve Therapeutics, Inc. develops therapies for editing the adult human genomes. It utilizes human genetic analysis and gene-editing technology for developing therapies to reduce the risk of coronary artery diseases. The company serves the biotechnology and health care sectors. It has a strategic alliance with Beam Therapeutics for developing delivery technologies against cardiovascular targets; and Verily, for the development of gene editing delivery vehicles. Verve Therapeutics, Inc. was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in September 2019. The company was founded in 2018 and is based in Cambridge, Massachusetts with a research facility in Philadelphia, Pennsylvania.

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Wellframe is a hospital and healthcare it provides a digital health management solutions that include care management support, digital concierge solutions, and transformation services. It helps healthcare organizations by providing solutions that enable them to support people longitudinally between traditional clinical interactions. The company was founded in 2011 and headquartered in Boston, Massachusetts, United States.

Founded in 2015, Even Financial is an NYC based fintech company focused on evolving how financial institutions connect with consumers and provide them the best product recommendations at the right moment, facilitating an on-demand and personalized customer acquisition experience across the entire financial services ecosystem. The Even platform serves as a trusted intermediary for financial institutions - including Prosper, Lending Club, and Marcus by Goldman Sachs - that helps find consumers and distribute their products digitally. Even’s industry-leading search, comparison, and recommendation API is an infrastructure layer that enables hundreds of diverse partners - including Credit.com, Transunion, Money Under 30, Credit Sesame, and The Penny Hoarder - to power comprehensive personal finance websites, mobile apps, and other offerings with a modern platform that is proven to accelerate customer acquisition through optimal product recommendations, lowering cost of acquisition and maximizing monetization. Even Financial is based in New York.

Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.

WellAir delivers energy-efficient technologies that enable safe indoor spaces for the health and wellbeing of all individuals. WellAir’s mission is to mitigate microorganisms that lead to infectious diseases, including viruses, by delivering innovative and powerful air cleaning technology and surface disinfection devices.

Haiui Health Technology is a mobile platform for hospitals to connect patients, optimise hospital visits and streamline admin workflow.

Burro is a mobile application for Android and iOS devices that offers delivery and on-demand moving services to its users. The application enables its users to request pickups by filling up their personal information and items required. The platform offers its services to individuals and businesses. Its delivery portfolio consists of household goods, carpets, wood, and retail store items. Burro was launched in 2014 by Jason Ervin and Ethan Hurtado and is based in Texas.

Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

Yisheng Biopharma Co., Ltd., a biopharmaceutical company, researches, develops, manufactures, and markets immuno-oncology products and vaccines. It offers YS-ON-001, an investigational biological product that demonstrates immuno-modulating effects, such as induction of anti-tumor cytokines, activation of NK cells, regulation of macrophage polarization, and suppression of regulatory T cells for the treatment of advanced solid tumors. Yisheng Biopharma Co., Ltd. was founded in 2002 and is based in Beijing with operations in China, the United States, Cambodia, and Singapore.

Yisheng Biopharma Co., Ltd., a biopharmaceutical company, researches, develops, manufactures, and markets immuno-oncology products and vaccines. It offers YS-ON-001, an investigational biological product that demonstrates immuno-modulating effects, such as induction of anti-tumor cytokines, activation of NK cells, regulation of macrophage polarization, and suppression of regulatory T cells for the treatment of advanced solid tumors. Yisheng Biopharma Co., Ltd. was founded in 2002 and is based in Beijing with operations in China, the United States, Cambodia, and Singapore.

The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Immuneel Therapeutics provides pioneering cell and gene therapies for cancer treatment. They develop CAR-T cell therapies from patients' blood cells by genetically modifying healthy immune cells to target malignant cells, giving cancer patients access to revolutionary cell-based immunotherapies.